Adding growth levers in hospitalhealthco business

Company
25 Nov 2024
5 Min read 
  • Tushar Manudhane recommends buying Apollo Hospitals stock with a target price of INR 8,020, representing a 16% increase.
  •  The company plans to add 2,860 beds over the next three years, focusing on expanding its hospital and healthco business.
  •  Financials snapshot shows growth in sales, EBITDA, and adjusted PAT over the next three years.
  •  Apollo Hospitals is valued on an SOTP basis to arrive at the target price of INR 8,020.
  •  The company is expected to witness growth in GMV and profitability through the launch of new products and services.
  •  The stock performance over the past year has been positive, and the company has received investments from Advent International to support its growth plans.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority

Click here to see your activities